NuVasive, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$147.8M
Doctors Paid
6,660
Transactions
97,679
2023 Total
$21.6M
Payment Breakdown by Category
Royalty/License$98.0M (66.3%)
Consulting$23.4M (15.8%)
Travel$6.6M (4.4%)
Research$6.2M (4.2%)
Food & Beverage$3.3M (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $98.0M | 2,795 | 66.3% |
| Consulting Fee | $23.4M | 5,503 | 15.8% |
| Grant | $7.4M | 279 | 5.0% |
| Travel and Lodging | $6.6M | 27,623 | 4.4% |
| Unspecified | $6.2M | 1,855 | 4.2% |
| Food and Beverage | $3.3M | 58,433 | 2.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $2.4M | 780 | 1.6% |
| Space rental or facility fees (teaching hospital only) | $440,552 | 69 | 0.3% |
| Education | $70,640 | 165 | 0.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $41,725 | 9 | 0.0% |
| Charitable Contribution | $41,500 | 2 | 0.0% |
| Entertainment | $6,480 | 152 | 0.0% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $5,000 | 1 | 0.0% |
| Gift | $1,097 | 13 | 0.0% |
Payments by Type
General
$141.6M
95,824 transactions
Research
$6.2M
1,848 transactions
Ownership
$0
7 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| NUVA.LIB1119: A prospective, multicenter study evaluating the safety and performance of interbody implants for the treatment of patients with degenerative conditions of the thoracic and/or lumbar spine | $1.1M | 1 | 190 |
| NUVA.IGA1503 A Prospective Multicenter Study Evaluating the Clinical and Radiographic Outcomes of Thoracolumbar Spine Surgery When Comprehensive Sagittal Alignment Surgical Planning is Used | $848,535 | 2 | 251 |
| NUVA.X1801: A Prospective Multicenter Study Evaluating the Effect of Implant Material and/or Surface Structure on Progression of Fusion in XLIF?? Surgery | $438,243 | 0 | 146 |
| Two Level Simplify Cervical Artificial Disc PAS Study | $320,174 | 2 | 111 |
| A prospective, multicenter study evaluating the safety and performance of interbody implants for the treatment of patients with degenerative conditions of the thoracic and/or lumbar spine | $273,801 | 0 | 80 |
| NUVA.CIB0420: A prospective, multicenter study evaluating the safety and performance of interbody implants for the treatment of patients with degenerative conditions of the cervical spine | $239,020 | 0 | 57 |
| Simplify Disc One Level Post Approval Study | $216,086 | 4 | 93 |
| A Prospective Multicenter Study Evaluating the Effect of Implant Material and/or Surface Structure on Progression of Fusion in XLIF Surgery | $208,919 | 0 | 111 |
| NUVA.NV1401 A Prospective Non-randomized Multicenter Evaluation of the Utility of Transcutaneous Stimulation of the Lumbosacral Nerve Roots During XLIF and its Relationship to Postoperative Nerve Health | $188,093 | 3 | 60 |
| PSF: MAGEC | $180,315 | 0 | 5 |
| Two Level Simplify Cervical Artificial Disc IDE Study | $147,336 | 1 | 33 |
| NUVA.X1801 A Prospective Multicenter Study Evaluating the Effect of Implant Material and/or Surface Structure on Progression of Fusion in XLIF?? Surgery | $128,312 | 0 | 61 |
| NUVA.X1801 A Prospective Multicenter Study Evaluating the Effect of Implant Material andor Surface Structure on Progression of Fusion in XLIF Surgery | $122,180 | 0 | 70 |
| CLINICAL STUDY PROTOCOL for the INVESTIGATION Of The Two Level SIMPLIFY CERVICAL ARTIFICIAL DISC | $109,504 | 2 | 66 |
| A Prospective, Multicenter Study Evaluating the Safety and Performance of Interbody Implants for the Treatment of Patients With Degenerative Conditions of the thoracic and/or lumbar spine | $98,148 | 0 | 14 |
| NUVA.ACP0721: A prospective, multicenter study evaluating the safety and performance of the NuVasive?? ACP System for the treatment of patients with pathologic conditions of the cervical spine | $93,540 | 0 | 18 |
| Prospective Multi-Center Minimally Invasive Adult Spinal Deformity Outcomes Database Registry | $85,591 | 0 | 1 |
| NUVA.TDR0921 Long-Term Assessment of the NuVasive Simplify Disc | $85,545 | 0 | 39 |
| A Prospective, Multicenter Study Evaluating the Safety and Performance of Interbody Implants for the Treatment of Patients With Degenerative Conditions of the Cervical Spine | $83,987 | 0 | 12 |
| BUCKLAND Base and Brigade in Lateral ALIF | $80,000 | 0 | 1 |
| Multi Center Minimally Invasive Versus Open Adult Spinal Deformity Outcomes | $75,126 | 0 | 1 |
| Long-term Assessment of the Safety and Performance of the NuVasive Simplify Disc | $73,089 | 1 | 35 |
| Retrospective Evaluation of the PRECICE Intramedullary Lengthening System in the Pediatric and Adolescent Population | $71,850 | 0 | 1 |
| Post-Approval Study Protocol for theSimplifyCervical Artificial Disc | $70,791 | 0 | 14 |
| POST APPROVAL STUDY PROTOCOL FOR THE TWO LEVEL SIMPLIFY CERVICAL ARTIFICIAL DISC | $58,482 | 1 | 38 |
| Evaluation of a Computer Assisted Rod Bending System (Bendini) | $55,500 | 0 | 1 |
| NUVA.MSK1901: Prediction of Postoperative Global Sagittal Alignment Using Musculoskeletal Modeling ??? Validation Study | $55,250 | 0 | 2 |
| NUVA.IGA1502 The Relationship Between Standing and Recumbent Surgical Lumbar Lordosis: A Prospective Multicenter Quality Assurance Evaluation | $41,870 | 3 | 60 |
| An Assessment of the Safety and Performance of the Modulus ALIF System in Patients Undergoing Anterior Lumbar Interbody Fusion | $39,730 | 0 | 7 |
| NUVA.PCF1020: A prospective, multicenter study evaluating the safety and performance of posterior fixation in trauma, reconstructive, and tumor surgery of the occipito-cervico-thoracic spine. | $37,143 | 1 | 13 |
Payments by Medical Specialty
Top Paid Doctors — Page 267
| Doctor | Specialty | Location | Total | 2018 |
|---|---|---|---|---|
| Lucien Miranne, M.d, M.D | Neurological Surgery | Metairie, LA | $10.93 | $0 |
| Jemiel Nejim, M.d, M.D | Anesthesiology | New York, NY | $10.85 | $0 |
| Edie Zusman, Md, MD | Neurological Surgery | Fairfield, CA | $10.85 | $0 |
| Dr. Ira Fedder, M.d, M.D | Orthopaedic Surgery of the Spine | Towson, MD | $10.80 | $0 |
| Dr. Phillip Esce, M.d, M.D | Neurological Surgery | Spartanburg, SC | $10.72 | $0 |
| Mark Moulton, M.d, M.D | Orthopaedic Surgery | Muskegon, MI | $10.59 | $0 |
| Glenn Islat, Md, MD | Anesthesiology | Phoenix, AZ | $10.51 | $0 |
| Tsinsue Chen, M.d, M.D | Neurological Surgery | Chandler, AZ | $10.51 | $0 |
| Dr. Ravi Vaswani, M.d, M.D | Orthopaedic Surgery | Wesley Chapel, FL | $10.50 | $0 |
| Hannah Lee, Md, MD | Hand Surgery | Philadelphia, PA | $10.50 | $0 |
Ad
Top Products
- RELINE $24.6M
- XLIF $24.1M
Associated Products (55)
- RELINE $28.6M
- XLIF $26.1M
- ALIF $9.7M
- Modulus $8.9M
- Precept $6.6M
- CoRoent $6.6M
- Brigade $6.1M
- Pulse $5.4M
- VuePoint $4.7M
- BASE $4.5M
- COHERE $4.0M
- TLIF $3.6M
- Armada $2.8M
- TLX $2.3M
- Simplify Cervical Artificial Disc $2.0M
- Archon $1.9M
- Bendini $1.7M
- VersaTie $1.7M
- MAGEC $1.5M
- NVM5 $1.5M
- PLIF $1.4M
- MaXcess $1.0M
- iGA $1.0M
- COALESCE $981,684
- XLX $938,459
- Affix $927,491
- AttraX $836,663
- ACP $818,596
- MAGEC Spinal Bracing and Distraction System $785,142
- LessRay $722,688
- Nuvaline/NuvaMap O.R. $711,439
- NuvaLine/NuvaMap O.R. $555,092
- X-CORE $483,155
- MLX $397,412
- SpheRx $377,749
- Leverage $340,173
- X-Core Mini $282,671
- Monolith $228,553
- POWER $195,269
- Helix $179,338
- Traverse $92,581
- Osteocel $78,062
- ILIF $58,841
- Gradient $52,555
- MaXcess-C $46,462
- Triad $44,010
- Graft Delivery System $31,949
- PCM $28,940
- Coalesce $23,625
- PEEK Corpectomy $21,696
- Excavation $20,597
- ExtenSure $19,916
- Propel $18,599
- Mesh $14,072
- NuVasive $10,273
Payment Categories
- Food & Beverage $3.3M
- Consulting $23.4M
- Travel & Lodging $6.6M
- Research $6.2M
- Royalties $98.0M
About NuVasive, Inc.
NuVasive, Inc. has made $147.8M in payments to 6,660 healthcare providers, recorded across 97,679 transactions in the CMS Open Payments database. In 2023, the company paid $21.6M. The top product by payment volume is RELINE ($24.6M).
Payments were distributed across 152 medical specialties. The top specialty by payment amount is Neurological Surgery ($63.7M to 1,832 doctors).
Payment categories include: Food & Beverage ($3.3M), Consulting ($23.4M), Research ($6.2M), Travel & Lodging ($6.6M), Royalties ($98.0M).
NuVasive, Inc. is associated with 55 products in the CMS Open Payments database, including RELINE, XLIF, and ALIF.